Observer
  • Business
  • Art
  • Lifestyle
Newsletters
  • Business
    • Finance
    • Media
    • Technology
    • Policy
    • Wealth
    • Insights
    • Interviews
  • Art
    • Art Fairs
    • Art Market
    • Art Reviews
    • Auctions
    • Galleries
    • Museums
    • Interviews
  • Lifestyle
    • Nightlife & Dining
    • Style
    • Travel
    • Interviews
  • Power Index
    • Nightlife & Dining
    • Art
    • A.I.
    • PR
  • About
    • About Observer
    • Advertise With Us
    • Reprints
Newsletters

FDA

A robot hand optimizing medical processes

The Economics of Drug Development: What it Will Really Take to Reduce Drug Prices

Orr Inbar, CEO and co-founder of QuantHealth, unpacks the growing frustration over drug prices and the misperceptions fueling distrust in the pharmaceutical industry. With clinical trials now more expensive and less successful than ever, Inbar explores how A.I.-powered simulations can fundamentally change the economics of drug development, reducing development costs, boosting approval rates and ultimately bringing more affordable treatments to market.
By Orr Inbar
Food and Drug Administration Commissioner (FDA) Martin Makary waits for the start of a press conference.

New FDA Chief Martin Makary Says DOGE Cuts Haven’t Hit Science Staff

The new FDA chief reiterated his commitment to speeding up drug approval processes and run the agency by "gold standard science" and "common sense."
By Sissi Cao
Cellphone with 'Neuralink' logo displayed on screen

Elon Musk’s Neuralink Aims to Implant 10 Times More Brain Chips in 2025

Neuralink recently implanted its brain device into a third patient, according to Elon Musk.
By Alexandra Tremayne-Pengelly
Illustration of a small person surrounded by oversized hands and floating pills, symbolizing the impact and control of artificial intelligence and pharmaceutical companies over drug development and patient outcomes.

How A.I. Is Disrupting Pharma: The High-Stakes Race to Revolutionize Drug Discovery

By Rachel Curry
Neuralink

Elon Musk’s Neuralink Gets FDA Green Light to Implant Brain Chips in More Humans

By Sissi Cao

The Billionaires Pouring Millions into Psychedelic Therapy Research

By Alexandra Tremayne-Pengelly

The FDA Has Approved an Omicron Booster That Could Be Administered as Soon as Next Week

By Rachel Millman
A woman examines a patient with a red hearing aid.

Hearing Aids Will Now Be Available Over the Counter and Could Be Cheaper With a New FDA Rule

By Courtney Vinopal
A Daily Harvest meal kit

Multiple Daily Harvest Customers Had Organs Removed as Lawsuits Descend on the Meal Kit Company

By Alexandra Tremayne-Pengelly
Daily Harvest delivery box

Meal Kit Company Daily Harvest Is Investigating a Lentil Dish Linked to Serious Illnesses

By Alexandra Tremayne-Pengelly
Neuralink

Elon Musk’s Neuralink Is Preparing for Human Brain Chip Trial With Key Hires

By Sissi Cao

Yes, You Can Probably Mix and Match Different COVID-19 Vaccines According to Studies

By Sissi Cao

COVID-19 Is in Mysterious Retreat—Is the Worst of the Pandemic Behind Us?

By Sissi Cao

Former FDA Chief Says Pandemic Could Subside by Thanksgiving—If Delta Is the Last Major Variant

By Sissi Cao

Here’s Who Should Get a 3rd Pfizer Shot According to the CDC’s Latest Recommendation

By Sissi Cao

CDC Convenes to Decide Who Will Get Pfizer Booster Following FDA’s Surprise Vote

By Sissi Cao

Updated: Here’s What You Need to Know About the Pfizer COVID-19 Booster Shot Debate

By Sissi Cao

How Soon Will the FDA Fully Approve Moderna and J&J Vaccines?

By Sissi Cao

Rival of Elon Musk’s Neuralink Cleared by FDA to Test Brain Chip in Humans

By Sissi Cao

FDA Approves Biogen’s Controversial Alzheimer’s Drug That Costs $56K a Year

By Sissi Cao

FDA Authorizes the First Brain-Computer Interface Device (It’s Not Musk’s Neuralink )

By Sissi Cao

Comparing Johnson & Johnson’s Vaccine With Moderna, Pfizer’s Now That It’s Approved

By Sissi Cao

Moderna’s COVID-19 Vaccine Is About to Change the Game for Americans

By Sissi Cao

FDA Authorizes COVID Vaccine. So How Can You Actually Get It?

By Sissi Cao
More
  • ART
  • BUSINESS
  • LIFESTYLE
  • POWER LISTS
  • INTERVIEWS
  • ABOUT
  • ADVERTISE
  • CONTACT
  • NEWSLETTERS
  • RSS FEEDS
  • SITEMAP
  • TERMS
  • PRIVACY
  • REPRINTS
  • Privacy
  • Terms
  • Cookie Settings
  • Do not sell my data
Powered by WordPress VIP

We noticed you're using an ad blocker.

We get it: you like to have control of your own internet experience.
But advertising revenue helps support our journalism.

To read our full stories, please turn off your ad blocker.
We'd really appreciate it.

How Do I Whitelist Observer?

How Do I Whitelist Observer?

Below are steps you can take in order to whitelist Observer.com on your browser:

For Adblock:

Click the AdBlock button on your browser and select Don't run on pages on this domain.

For Adblock Plus on Google Chrome:

Click the AdBlock Plus button on your browser and select Enabled on this site.

For Adblock Plus on Firefox:

Click the AdBlock Plus button on your browser and select Disable on Observer.com.

Then Reload the Page